Delestrogen Articles
Bayer begins European roll-out of Qlaira
14 May 2009
King pays $285 million for B-MS drugs
10 August 2001
Schering AG's Climodien approved in EU
12 June 2001
Schering AG to "grow faster than market"
16 March 2001
Oral Fludara launched in first market
22 January 2001
Sanofi Launches New HRT Approach In UK
8 May 1995
Showing 1-6 of 6 articles
- 1
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Proposal to list Roche's Neulastim and Actemra in New Zealand
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
